Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform

Engineered viral vectors represent a promising strategy to trigger antigen-specific antitumor T cell responses. Arenaviruses have been widely studied because of their ability to elicit potent and protective T cell responses. Here, we provide an overview of a novel intravenously administered, replica...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauterbach, Henning, Schmidt, Sarah, Katchar, Kia, Qing, Xiaoping, Iacobucci, Corinne, Hwang, Andy, Schlienger, Katia, Berka, Ursula, Raguz, Josipa, Ahmadi-Erber, Sarah, Schippers, Timo, Stemeseder, Felix, Pinschewer, Daniel D., Matushansky, Igor, Orlinger, Klaus K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551556/
https://www.ncbi.nlm.nih.gov/pubmed/34722273
http://dx.doi.org/10.3389/fonc.2021.732166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551556/
https://www.ncbi.nlm.nih.gov/pubmed/34722273
http://dx.doi.org/10.3389/fonc.2021.732166

Ejemplares similares